Mauro Avanzi, MD, PhD, has been appointed chief medical officer of Shoreline Biosciences, a biopharmaceutical company focused on developing cellular immunotherapies based on induced pluripotent stem cells.
Dr. Avanzi most recently served as vice president of clinical development at Neogene Therapeutics, according to a Feb. 21 release announcing his appointment. While at Neogene, he oversaw clinical studies on TCR T cells targeting neoantigens.
Dr. Avanzi has also held a variety of positions at Kite Pharma, including medical director and senior medical director before serving as executive medical director from 2020 to 2021, according to LinkedIn.
HCA Florida Northwest Hospital in Margate, Fla., has announced the addition of Victor Jaffe, DO, as its new chief medical…
Danville, Pa.-based Geisinger Health has named Jason Mitchell, MD, as its new executive vice president and chief medical officer.
Here are five CMO exits that occurred in 2024, as reported by Becker's:
Comments are closed.